We are live on ! Find out more
FCM

Farallon Capital Management Portfolio holdings

AUM $17.5B
1-Year Est. Return 50.95%
This Fund
S&P 500
This Quarter Est. Return
+9%
1 Year Est. Return
+50.95%
3 Year Est. Return
+148.38%
5 Year Est. Return
+206.05%
10 Year Est. Return
+1,475.31%
AUM
$24.5B
AUM Growth
+$4.37B
Cap. Flow
+$2.47B
Cap. Flow %
10.08%
Top 10 Hldgs %
39.35%
Holding
397
New
164
Increased
36
Reduced
47
Closed
100

Top Buys

Rank Stock Value
1
NUAN
Nuance Communications, Inc.
NUAN
+$387M
2
ALXN
Alexion Pharmaceuticals
ALXN
+$332M
3
NOW icon
ServiceNow
NOW
+$265M
4
NYT icon
New York Times
NYT
+$189M
5
MXIM
Maxim Integrated Products
MXIM
+$152M

Top Sells

Rank Stock Value
1
GOOG icon
Alphabet (Google) Class C
GOOG
+$456M
2
IPHI
INPHI CORPORATION
IPHI
+$311M
3
IQV icon
IQVIA
IQV
+$278M
4
GWPH
GW Pharmaceuticals Plc American Depositary Shares
GWPH
+$277M
5
EDU icon
New Oriental
EDU
+$192M

Sector Composition

Rank Sector Weight
1 Healthcare 29.35%
2 Financials 13%
3 Technology 12.06%
4 Communication Services 9.43%
5 Industrials 7.22%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BIIB icon
76
Biogen
BIIB
$30.7B
$37.7M 0.15%
109,000
+6,000
+6% +$1.82M
TPTX
77
DELISTED
Turning Point Therapeutics, Inc. Common Stock
TPTX
$36.3M 0.15%
465,000
-35,000
-7% -$2.59M
QTRX icon
78
Quanterix
QTRX
$190M
$32M 0.13%
545,000
-55,000
-9% -$3.19M
EXAS
79
DELISTED
Exact Sciences
EXAS
$31.1M 0.13%
+250,000
New +$29.8M
ANNX icon
80
Annexon
ANNX
$886M
$30.6M 0.12%
1,358,107
-97,739
-7% -$2.17M
ARWR icon
81
Arrowhead Research
ARWR
$12.4B
$30.2M 0.12%
365,000
+192,546
+112% +$14.3M
TVRD
82
Tvardi Therapeutics
TVRD
$23.4M
$28.5M 0.12%
55,556
-12,916
-19% -$8.18M
KVSC
83
DELISTED
Khosla Ventures Acquisition Co. III Class A Common Stock
KVSC
$27.8M 0.11%
2,809,000
– –
AJRD
84
DELISTED
Aerojet Rocketdyne Holdings
AJRD
$26.3M 0.11%
+545,000
New +$26.2M
TLND
85
DELISTED
Talend S.A. American Depositary Shares
TLND
$24.9M 0.1%
+380,000
New +$24.6M
PNT
86
DELISTED
POINT Biopharma Global Inc. Common Stock
PNT
$24.7M 0.1%
+2,400,000
New +$24.4M
CLVR
87
DELISTED
Clever Leaves Holdings Inc. Common Shares
CLVR
$24.6M 0.1%
84,792
+8,856
+12% +$2.73M
NUVB icon
88
Nuvation Bio
NUVB
$2.32B
$23.3M 0.1%
2,498,600
-1,400
-0.1% -$16K
NXDR
89
Nextdoor Holdings
NXDR
$986M
$22.3M 0.09%
2,250,000
– –
QSI icon
90
Quantum-Si Incorporated
QSI
$177M
$21.5M 0.09%
+1,750,000
New +$18.3M
AUS
91
DELISTED
Austerlitz Acquisition Corporation I
AUS
$20.9M 0.09%
+2,109,700
New +$20.9M
DCRC
92
DELISTED
Decarbonization Plus Acquisition Corporation III Class A Common Stock
DCRC
$20.7M 0.08%
+2,000,000
New +$20.9M
RC
93
Ready Capital
RC
$308M
$19.8M 0.08%
1,250,226
– –
REVH
94
DELISTED
Revolution Healthcare Acquisition Corp. SAIL Class A Common Stock
REVH
$19.6M 0.08%
+2,000,000
New +$19.7M
TGTX icon
95
TG Therapeutics
TGTX
$7.62B
$19.4M 0.08%
500,000
– –
NEO icon
96
NeoGenomics
NEO
$2.13B
$19M 0.08%
+420,000
New +$18.6M
FVIV
97
DELISTED
Fortress Value Acquisition Corp. IV
FVIV
$17.2M 0.07%
+1,750,000
New +$17.2M
SHQAU
98
DELISTED
Shelter Acquisition Corporation I Units
SHQAU
$16.5M 0.07%
+1,650,000
New +$16.5M
RCEL icon
99
Avita Medical
RCEL
$239M
$16.4M 0.07%
800,000
– –
IMA
100
ImageneBio Inc
IMA
$64.6M
$15.7M 0.06%
93,112
-19,347
-17% -$4.27M
2 3
4
5 6

Similar funds

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
MCM
MAI Capital Management Independence, Ohio $17.7B AUM 18.87% 1-Year Est. Return
LA
Linden Advisors New York $17.9B AUM 1.72% 1-Year Est. Return
CM
Caption Management Oklahoma City, Oklahoma $17.1B AUM 70.99% 1-Year Est. Return
ASRS
Arizona State Retirement System Phoenix, Arizona $17.1B AUM 30.52% 1-Year Est. Return
PP
Prudential plc London, England, United Kingdom $17.1B AUM 15.7% 1-Year Est. Return
VMPIC
Varma Mutual Pension Insurance Co Helsinki, Finland $17B AUM 24.09% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Farallon Capital Management's Q2 2021 Portfolio in Review

As of Q2 2021, Farallon Capital Management held 397 positions worth $24.5B, up 22% from $20.1B the previous quarter. Its ten largest holdings account for 39% of the portfolio.

Farallon Capital Management deployed $2.47B of net new capital in Q2 2021, opening 164 new positions and adding to 36 existing holdings. Its largest new stake was Nuance Communications, Inc.: 7,337,500 shares worth $399M.

By sector, the portfolio is most concentrated in Healthcare at 29% of assets, down from 35% a quarter earlier, followed by Financials and Technology.

On the sell side, the largest reduction was Alphabet (Google) Class C, an estimated $456M trimmed.

  • Farallon Capital Management's largest Q2 2021 buy was Nuance Communications, Inc.: 7,337,500 shares worth $399M.
  • Farallon Capital Management added most to Alexion Pharmaceuticals in Q2 2021, an estimated $332M increase.
  • Farallon Capital Management's biggest Q2 2021 reduction was Alphabet (Google) Class C, cutting an estimated $456M.
  • Farallon Capital Management fully exited INPHI CORPORATION in Q2 2021, selling an estimated $311M.
  • Farallon Capital Management's ten largest holdings make up 39% of its $24.5B portfolio in Q2 2021.
  • Farallon Capital Management opened 164 new positions and closed 100 in Q2 2021.
  • Farallon Capital Management's portfolio value rose 22% quarter-over-quarter to $24.5B.

Based on Farallon Capital Management's 13F filing for Q2 2021, filed 13 Aug 2021.